Neimeth Reports 211% Net Profit Growth for 2025

Neimeth International Pharmaceuticals Plc announced a remarkable 211% growth in net profit in its unaudited report for the fourth quarter ending December 31, 2025. The company reported a net profit of N982.11 million, a significant recovery from a loss of N885.33 million in 2024.

Operating profit surged to N2.7 billion, marking a 14.257% increase, while profit before tax grew by 274%, from a loss of N854.546 million in 2024 to N1.48 billion in 2025. The business year saw sales revenue rise to N7.37 billion, reflecting a 64% increase from N4.49 billion in 2024.

Mr. Valentin Okelu, the Managing Director and CEO, attributed this exceptional growth trajectory to strategic planning, prudent spending, cost-effectiveness, and efficient market routes.

He assured shareholders and stakeholders of Neimeth's commitment to doubling earnings and capturing the continental market, emphasizing the company's rich history in pharmaceutical products in Nigeria.